(JPX4) Amundi Index Solutions - Ratings and Ratios
Japan Stocks, Equity Funds, Index Tracker, Ucits Etf
Description: JPX4 Amundi Index Solutions
Amundi Index Solutions - Amundi Index MSCI Japan SRI PAB UCITS ETF DR (C) EUR is an exchange-traded fund (ETF) that tracks the Morningstar Japan TME NR JPY index, providing exposure to Japanese large-cap equities with a blend style. The fund is domiciled in France and has a substantial Assets Under Management (AUM) of approximately €56.03 billion.
The ETFs investment strategy focuses on sustainable and responsible investing (SRI), adhering to the Paris-Aligned Benchmark (PAB) standards, which aim to achieve long-term climate objectives. By tracking the Morningstar Japan TME NR JPY index, the fund provides investors with a diversified portfolio of Japanese equities that meet specific environmental, social, and governance (ESG) criteria.
To evaluate the funds performance, key performance indicators (KPIs) such as tracking error, information ratio, and ESG scores can be considered. A low tracking error would indicate that the ETF is effectively replicating the underlying index, while a high information ratio would suggest that the fund is generating excess returns relative to its benchmark. Additionally, a high ESG score would reflect the funds commitment to sustainable investing and its alignment with the PAB standards.
From a technical analysis perspective, the ETFs price action can be monitored using indicators such as moving averages, relative strength index (RSI), and Bollinger Bands. For instance, the funds current price is below its 20-day and 50-day simple moving averages (SMA20 and SMA50), indicating a potential short-term downtrend. Furthermore, the average true range (ATR) of 0.39 represents a daily price volatility of 0.88%, which can be used to gauge the funds risk profile.
JPX4 ETF Overview
| Market Cap in USD | 43,441m |
| Category | Japan Large-Cap Blend Equity |
| TER | 0.18% |
| IPO / Inception | 2020-10-13 |
JPX4 ETF Ratings
| Growth Rating | -69.7 |
| Fundamental | 45.0% |
| Dividend Rating | - |
| Rel. Strength | -13.3 |
| Analysts | - |
| Fair Price Momentum | 36.67 EUR |
| Fair Price DCF | - |
JPX4 Dividends
Currently no dividends paidJPX4 Growth Ratios
| Growth Correlation 3m | -30.9% |
| Growth Correlation 12m | -56.6% |
| Growth Correlation 5y | -67.2% |
| CAGR 5y | -20.04% |
| CAGR/Max DD 5y | -0.25 |
| Sharpe Ratio 12m | -0.89 |
| Alpha | -15.28 |
| Beta | 0.803 |
| Volatility | 16.44% |
| Current Volume | 0.3k |
| Average Volume 20d | 3.1k |
| Stop Loss | 44.8 (-3%) |
As of August 10, 2025, the stock is trading at EUR 46.20 with a total of 260 shares traded.
Over the past week, the price has changed by +4.49%, over one month by +6.48%, over three months by +2.09% and over the past year by +5.32%.
No, based on ValueRay´s Fundamental Analyses, Amundi Index Solutions (PA:JPX4) is currently (August 2025) a stock to sell. It has a ValueRay Fundamental Rating of 45.00 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JPX4 is around 36.67 EUR . This means that JPX4 is currently overvalued and has a potential downside of -20.63%.
Amundi Index Solutions has no consensus analysts rating.
According to our own proprietary Forecast Model, JPX4 Amundi Index Solutions will be worth about 40.9 in August 2026. The stock is currently trading at 46.20. This means that the stock has a potential downside of -11.56%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 40.9 | -11.6% |
ValueRay Score 45.00
| 1. Piotroski 0.0pt = -5.0 |
JPX4 Fundamental Data Overview
Market Cap EUR = 37.25b (37.25b EUR * 1.0 EUR.EUR)
[93m CCE Cash And Equivalents = unknown
[39m[93m Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 EUR
[39m Beta = 1.05
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
[93m Long Term Debt = unknown (none)
[39m[93m Short Term Debt = unknown (none)
[39m[93m Debt = unknown
[39m[93m Net Debt = unknown
[39m Enterprise Value = 37.25b EUR (37.25b + (null Debt) - (null CCE))
[93m Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
[39m[93m FCF Yield = none (FCF TTM 0.0 / Enterprise Value 37.25b)
[39m[93m FCF Margin = unknown (Revenue TTM is 0)
[39m[93m Net Margin = unknown
[39m[93m Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
[39m[93m Tobins Q-Ratio = unknown (Enterprise Value 37.25b / Book Value Of Equity 0.0)
[39m Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
[93m Taxrate = unknown
[39m[93m NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
[39m[93m Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
[39m[93m Debt / Equity = unknown Debt (none)
[39m[93m Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
[39m[93m Debt / FCF = none (Debt none / FCF TTM 0.0)
[39m[93m Total Stockholder Equity = unknown
[39m[93m RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
[39m[93m RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
[39m[93m RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
[39m[93m WACC = unknown (E(37.25b)/V(0.0) * Re(8.97%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
[39m Discount Rate = 8.97% (= CAPM, Blume Beta Adj.)
[93m Fair Price DCF = unknown (Cash Flow 0.0)
[39m